[Use of Bacillus megaterium H. in studying the antitumor properties of new ethyleneimine derivatives of N-dichlorophosphonyliminotri-chloroacetic acid trichlorophosphopolyalkane halides and chloroanhydridies].
D000818:Animals; D000970:Antineoplastic Agents; D001388:Aziridines / Q000494:pharmacology*; D001389:Azirines / Q000494:pharmacology*; D001407:Bacillus / Q000187:drug effects*; D004353:Drug Evaluation, Preclinical; D007928:Lethal Dose 50; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009943:Organophosphorus Compounds / Q000494:pharmacology*; D051381:Rats; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D001388:Aziridines; D001389:Azirines; D009943:Organophosphorus Compounds
Ispol'zovanie Bacillus megaterium H. pri issledovanii protivoopukholevykh svoĭstv novykh étileniminnykh proizvodnykh trikhlorfosfazopoligaloidalkanov i khlorangidridov N-dikhlorfosfoniliminotrikhloruksusnoĭ kisloty.